openPR Logo
Press release

Albumin Market Size (USD 8.95 Billion by 2030) Set to Reach New Heights: Analysis of Trends and Growth Drivers

05-30-2023 10:05 AM CET | Health & Medicine

Press release from: Allied Market Research (AMR)

Albumin Market

Albumin Market

Allied Market Research has published a study report with the title Albumin Market Size was Valued at ๐”๐’๐ƒ ๐Ÿ’.๐Ÿ–๐Ÿ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐ŸŽ, and is Anticipated to Garner ๐”๐’๐ƒ ๐Ÿ–.๐Ÿ—๐Ÿ“ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐ŸŽ, registering a ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ”.๐Ÿ’% from 2021 to 2030.The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ ๐จ๐Ÿ ๐‚๐Ž๐•๐ˆ๐ƒ-๐Ÿ๐Ÿ— ๐จ๐ง ๐ญ๐ก๐ž ๐€๐ฅ๐›๐ฎ๐ฆ๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ-

โ€ข Increasing use of albumin for the production of vaccines such as Covaxin and Covishield for the treatment of COVID-19 infections has impacted the global albumin market positively.
โ€ข Persistent innovations by prominent players and growing number of product approvals have again been beneficial for the industry.

๐–๐ก๐š๐ญ ๐š๐ซ๐ž ๐ญ๐ก๐ž ๐ƒ๐ซ๐ข๐ฏ๐ข๐ง๐  ๐…๐š๐œ๐ญ๐จ๐ซ๐ฌ ๐Ž๐Ÿ ๐€๐ฅ๐›๐ฎ๐ฆ๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ?

Significant surge in non-therapeutic application of albumin, increasing production of immunoglobulins & plasma collection, and growth in the development of plant-based albumin are expected to drive the growth of the global albumin market. On the other hand, stringent regulations imposed by several government bodies on the adoption of albumin products impede the growth to some extent. However, increase in the number of cancer surgeries that lead to cause hypoalbuminemia is expected to create lucrative opportunities in the industry.

๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐†๐ซ๐š๐ฉ๐ก๐ฌ ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ ๐‡๐ž๐ซ๐ž:
https://www.alliedmarketresearch.com/request-sample/2583

๐“๐จ๐ฉ ๐€๐ฅ๐›๐ฎ๐ฆ๐ข๐ง ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ

โ€ข Takeda Pharmaceuticals Inc
โ€ข Thermo Fisher Scientific
โ€ข Ventria Bioscience
โ€ข Baxter International Inc.
โ€ข China Biologic Products, Inc.
โ€ข Merck KGaA
โ€ข Novozymes
โ€ข Octapharma AG
โ€ข CSL Limited
โ€ข Grifols, S.A.

๐€๐ฅ๐›๐ฎ๐ฆ๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง: -

The global albumin market is analysed across type,
application and region.

By type, the human serum albumin segment held the largest share in 2020, garnering around two-third of the total market. This segment is also expected to cite the fastest CAGR of 6.8% during the forecast period.

By application, the therapeutics segment generated the highest market share in 2020, accounting nearly two-fifths of the global market. This segment would also exhibit the fastest CAGR of 6.7% during the forecast period.

By region, the market across North America held the lion's share in 2020, garnering nearly half of the global market. The Asia-Pacific region, on the other hand, is expected to cite the fastest CAGR of 7.7% during the forecast period.

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.alliedmarketresearch.com/purchase-enquiry/2583

Key Benefits for Stakeholders

โ€ข The study provides an in-depth analysis of the albumin market, and the current trends & future estimations to elucidate imminent investment pockets.
โ€ข It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
โ€ข Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
โ€ข Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

โ€ข Which are the driving factors responsible for the growth of market?
โ€ข Which are the roadblock factors of this market?
โ€ข What are the new opportunities, by which market will grow in coming years?
โ€ข What are the trends of this market?
โ€ข Which are main factors responsible for new product launch?
โ€ข How big is the global & regional market in terms of revenue, sales and production?
โ€ข How far will the market grow in forecast period in terms of revenue, sales and production?
โ€ข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โ€ข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โ€ข Which region has more opportunities?

By Region Outlook

โ€ข North America
(U.S., Canada, Mexico)
โ€ข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โ€ข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โ€ข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Albumin Market Size (USD 8.95 Billion by 2030) Set to Reach New Heights: Analysis of Trends and Growth Drivers here

News-ID: 3071057 • Views: โ€ฆ

More Releases from Allied Market Research (AMR)

Smartwatch Industry expected to grow by $164.7 Billion By 2023-2032
Smartwatch Industry expected to grow by $164.7 Billion By 2023-2032
This report provides a quantitative analysis of the smartwatch market size, current trends, estimations, and dynamics of the smartwatch market analysis from 2022 to 2032 to identify the prevailing smartwatch market opportunity. The Global Smartwatch Market was valued at $42.7 billion in 2022, and is projected to reach $164.7 billion by 2032, growing at a CAGR of 14.5% from 2023 to 2032. Download Sample Report in PDF: https://www.alliedmarketresearch.com/request-sample/490 Alliedโ€ฆ
Enzymes Market Expected to Reach $10.2 Billion by 2031 | CAGR of 6%
Enzymes Market Expected to Reach $10.2 Billion by 2031 | CAGR of 6%
Enzymes market size was valued at $5.8 billion in 2021, and is estimated to reach $10.2 billion by 2031, growing at a CAGR of 6% from 2022 to 2031. Enzymes are biocatalysts, which alter the rate of various biochemical reactions. In the current scenario, enzymes serve as useful biocatalysts for several industrial processes and chemical reactions. Moreover, they play an important role in chemical engineering, food technology, and agriculture. Theโ€ฆ
Cancer Gene Therapy Market Reach $11.4 Billion by 2030 - depth analysis of current trends & future estimation
Cancer Gene Therapy Market Reach $11.4 Billion by 2030 - depth analysis of curre โ€ฆ
Cancer Gene Therapy Market size was valued at $1.4 billion in 2020, and is estimated to reach $11.4 billion by 2030, growing at a CAGR of 23.3% from 2021 to 2030. Cancer gene therapy is a technique used for the treatment of cancer where therapeutic DNA is being introduced into the gene of the patient with cancer. Owing to the high success rate during the preclinical and clinical trials, cancerโ€ฆ
Vascular Grafts Market Set to Expand $8.1 Billion by 2030 | CAGR of 4.98%
Vascular Grafts Market Set to Expand $8.1 Billion by 2030 | CAGR of 4.98%
Vascular graft market size was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 million by 2030, registering a CAGR of 4.98% from 2021 to 2030. Vascular grafting is done for the treatment of various vascular complications, such as coronary artery disease (CAD), pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and pediatric congenital cardiovascular defects (CCDs). The high blood pressure, cholesterol deposition,โ€ฆ

All 5 Releases


More Releases for Albumin

Albumin Market: Therapeutic Action of Albumin on Liver Function and Blood Circul โ€ฆ
The use of albumin to treat multiple types of deficiencies, including those related to blood volume, is giving an impetus to market growth. It is a high-utility, human-derived protein that has applications across a spectrum of medical operations. Conditions such as hypoalbuminemia, caused by severe injuries, and rapid protein loss due to third-degree burns can be effectively managed through intravenous administration of albumin. Furthermore, albumin administration is the last resortโ€ฆ
Albumin Market Geographical Segmentation, Competitive Analysis, Latest Rising Tr โ€ฆ
This intelligence report provides a comprehensive analysis of the Albumin Market. This includes investigating past progress, ongoing market scenarios, and future prospects. Accurate data on the products, strategies and market share of leading companies in this particular market are mentioned. This report provides a 360-degree overview of the global market's competitive landscape. The report further predicts the size and valuation of the global market during the forecast period. Albumin is aโ€ฆ
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and itsโ€ฆ
Albumin Market: Increase in Usage of Albumin as Multifunctional Excipient to Boo โ€ฆ
Transparency Market Research (TMR) has published a new report titled, โ€œAlbumin (as Excipient) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018โ€“2026โ€. According to the report, the global albumin (as excipient) market was valued at US$ 750 Mn in 2017 and is anticipated to reach US$ 1200 Mn by 2026 at a CAGR of over 5.0% from 2018 to 2026. Grant of regulatory approvals coupled withโ€ฆ
Albumin Market: Substantial Use of Human Serum Albumin as Pharmaceutical Excipie โ€ฆ
Albumin Market: Snapshot Prominent companies operating in the global albumin market are focusing on product and service extensions to grow their shares. This is serving to stoke competition in the market. In the near future, the competition is slated to intensify further on account of the savvy players striking partnerships or acquiring distributors to augment sales and expand businesses, globally. At the forefront of driving growth in the global albumin market isโ€ฆ
Albumin Market: Substantial Use of Human Serum Albumin as Pharmaceutical Excipie โ€ฆ
Albumin Market: Snapshot Prominent companies operating in the global albumin market are focusing on product and service extensions to grow their shares. This is serving to stoke competition in the market. In the near future, the competition is slated to intensify further on account of the savvy players striking partnerships or acquiring distributors to augment sales and expand businesses, globally. At the forefront of driving growth in the global albumin market isโ€ฆ